1. Ambani LM, Van Woert MH (1973) Start hesitation: side effect of long-term levodopa therapy. N Engl J Med 288: 1113–1115
2. Ballard PA, Tetrud JW, Langston JW (1985) Permanent human parkinsonism due to 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35: 949–956
3. Bannister R, Oppenheimer D (1982) Parkinsonism, system degenerations and autonomic failure. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworth, London, pp 174–190
4. Bemheimer H, Birkmayer W, Homykiewicz O, Jellinger K, Scitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 20: 415–455
5. Blin J, Bonnet A-M, Agid Y (1987) Does levodopa cause worsening of Parkinson’s disease? In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease, vol 2. Macmillan, Healthcare Information, Florham Park, New Jersey, pp 165–181